Victoria Sinclair

╔══════════════════════════════════════════════════════════════════╗
║ ECOM-CID BRIEF // LEGACY ASSET VS-01 ║
║ CLASSIFICATION: INTERNAL · TIER 1 · RECOVERY PENDING ║
╚══════════════════════════════════════════════════════════════════╝
SUBJECT Victoria Sinclair
FORMER ROLE CEO and majority shareholder,
Sinclair Industries / Sinclair Labs
(pre-acquisition)
STATUS Presumed deceased. Biological chassis
unrecoverable. Potential consciousness-bearing
artifact in custody.
LAST VERIFIED February 2026 - final audio signal during
airframe breakup, North Lake Superior,
02:15 local
▌ BACKGROUND
Heiress and operational head of the Sinclair scientific program; inherited the decommissioned Titan II missile-complex site in Bellevue from her father and built the primary MAX facility on top of it, retaining the full subterranean complex below grade as an extended secure laboratory footprint. Personally authorized the project's ethical workarounds and green-lit the pharmaceutical-testing substrate model that produced Specimen #621. Survived the S1E1 airstrike on her own primary laboratory by relocating to secondary medical care in Quebec.
▌ TRANSITION EVENT
Between 2024 and 2025, Sinclair underwent a partial biological-to-digital transition not formally documented in Sinclair Labs records. ECOM-CID believes this was an emergency measure, not a planned migration - she reportedly never recovered the ability to replicate the process. Her resulting chassis was a floating laptop-form cyborg rig with an external screen interface, powered off an onboard circulating coolant loop and externally maintainable via cranial module swaps.

▌ PRIOR ACTIVITY - POST-TRANSITION
Operated a subterranean successor facility in the Quebec sector, funded off the books and concealed from ECOM's post-acquisition audits. Held Specimen #621 in sealed containment (~262 days). Authored the Specimen #622 ("Fox") program as an upgraded, remotely-controllable variant. Ran the concurrent Benjamin Morgan cloning program (42 confirmed instances) attempting to impose nanite architecture on a pre-sentient host body - all failed. Following the final Morgan terminal event, ordered full facility shutdown and evacuation.

▌ EXTRACTION & LOSS
Q1 2026 ECOM compliance action against the Quebec site. Sinclair evacuated with skeleton crew, Specimen #622, and the Specimen #621 containment vessel. Private jet departed secondary airstrip bound for a claimed-owned island. Sinclair sealed herself in the cockpit and issued pilot instructions regarding unauthorized landing clearance. During transit, Specimen #622 breached protocol, defected, and triggered a decompression event that broke up the airframe over Lake Superior. Sinclair's signal cut off mid-transmission. Biological remains unrecovered.
▌ POST-LOSS ARTIFACT - FEB 2026
Recovered from the wreckage on the Paradise, MI shoreline - a matte-black object, briefcase-form, no visible seams, single small port. X-ray composition: human brain tissue, integrated circuitry, unknown power source. Shell companies trace title back to a Sinclair Labs subsidiary, making it lawful ECOM property under the post-takeover documentation. Currently in personal custody of CEO Valtorini. No known successful authentication attempt. No known external signal.
▌ CURRENT ASSESSMENT - Q2 2026
ECOM-CID cannot confirm whether the artifact contains a persistent Sinclair consciousness, a passive data backup, or neither. Passive sweep indicates the artifact is drawing power - non-negligible, not dormant. Recommend proceeding under the assumption that the subject may reactivate if a viable authentication or interface path is identified.
▌ OPERATIONAL NOTES / DIRECTIVE
- Artifact classification: CEO-hold. No transfer, no external analysis, no reverse-engineering contract without direct executive sign-off.
- Sinclair's personal authority over Specimen #621 and #622 does not transfer to ECOM on paper, but remains a live narrative risk - she could theoretically re-contest control of both subjects if reactivated.
- Public position: CEO died in a private aviation accident. Sinclair Labs consolidation into ECOM was already complete pre-event; no shareholder action required.
- If the artifact begins signaling externally, escalate to CEO directly. Do not engage internal R&D until the command chain has issued handling protocol.
- END OF FILE - DISTRIBUTION: ECOM-CID / TIER 1 AUTHORIZED ONLY